Drug Profile
Research programme: cancer vaccines - Treos Bio
Alternative Names: PolyPEPI 1212; PolyPEPI 1311; PolyPEPI 1411; PolyPEPI 621; PolyPEPI 821; PolyPEPI 916; PolyPEPI™ Immunotherapy Cancer VaccineLatest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Treos Bio
- Class Cancer vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bladder cancer; Breast cancer; Gastric cancer; Lung cancer; Malignant melanoma; Ovarian cancer
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for preclinical development in Bladder-cancer in United Kingdom (Parenteral)
- 28 Feb 2023 No recent reports of development identified for preclinical development in Gastric-cancer in United Kingdom (Parenteral)
- 28 Apr 2021 No recent reports of development identified for preclinical development in Breast-cancer in United Kingdom (Parenteral)